Pfizer takes big gene therapy step after acquisition in Chapel Hill – Triangle Business Journal
Triangle Business Journal |
Pfizer takes big gene therapy step after acquisition in Chapel Hill
Triangle Business Journal The new trial underway is a Phase 1b clinical trial for a gene therapy candidate for the treatment of boys with Duchenne muscular dystrophy. Known as DMD, the rare genetic disease causes symptoms – usually emerging in children between the ages of just … |
